STUDY ON PAIN RELIEF BY GABAPENTIN AND PREGABALIN IN THE PATIENT COMPLAINING PAIN DUE TO CHEMOTHERAPY
Not Applicable
- Conditions
- Health Condition 1: G63- Polyneuropathy in diseases classified elsewhere
- Registration Number
- CTRI/2024/02/062820
- Lead Sponsor
- nill
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Adult patients of both the sex.
2.Diagnosed cases of CIPN.
3.Completion of at least one cycle of chemotherapy irrespective of the type of cancer.
4.Patients willing to participate in the study.
5.Patients on Gabapentin or Pregabalin
6.All consecutive patients will be included
Exclusion Criteria
1.Pregnant and lactating women.
2.Non cooperative patients.
3.Patients participating in any other study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method pain scoreTimepoint: Change in pain will be assessed i.e. baseline 2nd week, 4th week and 8th week
- Secondary Outcome Measures
Name Time Method adverse events of Pregabalin & GabapentinTimepoint: adverse events will be assessed i.e. 2nd week, 4th week & 8th week